HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Minoru Okubo Selected Research

Glycogen Debranching Enzyme System (Glycogen Debranching Enzyme)

2/2015A founder AGL mutation causing glycogen storage disease type IIIa in Inuit identified through whole-exome sequencing: a case series.
11/2009Molecular features of 23 patients with glycogen storage disease type III in Turkey: a novel mutation p.R1147G associated with isolated glucosidase deficiency, along with 9 AGL mutations.
6/2009Distinct mutations in the glycogen debranching enzyme found in glycogen storage disease type III lead to impairment in diverse cellular functions.
10/2007A Japanese patient with cardiomyopathy caused by a novel mutation R285X in the AGL gene.
1/2006Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey.
1/2005Molecular characterization of Egyptian patients with glycogen storage disease type IIIa.
1/2002Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Minoru Okubo Research Topics

Disease

7Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2019 - 02/2002
7Glycogen Storage Disease Type III (Cori's Disease)
02/2015 - 01/2002
6Type 2 Diabetes Mellitus (MODY)
03/2021 - 06/2008
4Hypertension (High Blood Pressure)
03/2021 - 02/2012
4Hypertriglyceridemia
11/2017 - 11/2007
4Hypoglycemia (Reactive Hypoglycemia)
12/2016 - 10/2007
3Diabetes Mellitus
05/2019 - 04/2002
3Hyperglycemia
03/2018 - 12/2002
3Pancreatitis
09/2014 - 11/2007
3Hyperlipoproteinemia Type III (Broad Beta Disease)
12/2012 - 03/2002
2Sleep Apnea Syndromes (Sleep Apnea)
03/2021 - 08/2015
2Non-alcoholic Fatty Liver Disease
05/2019 - 11/2013
2Ketosis
03/2018 - 07/2013
2Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial)
11/2017 - 01/2015
2Cardiovascular Diseases (Cardiovascular Disease)
08/2015 - 12/2012
2Hepatomegaly
02/2015 - 10/2007
2Glycogen Storage Disease IIIA
09/2013 - 01/2005
2Nephrosclerosis
01/2013 - 03/2002
2Coronary Disease (Coronary Heart Disease)
06/2008 - 09/2007
1Lung Diseases (Lung Disease)
03/2021
1Dyslipidemias (Dyslipidemia)
03/2021
1Apnea
01/2019
1Adenocarcinoma
03/2018
1Albuminuria
01/2018
1Inborn Genetic Diseases (Disease, Hereditary)
11/2017
1Weight Gain
12/2016
1Insulinoma
03/2016
1Liver Cirrhosis (Hepatic Cirrhosis)
09/2013
1Insulin Resistance
07/2013
1Inflammation (Inflammations)
01/2013
1Cerebral Hemorrhage
01/2013
1Anemia
01/2013
1Multi-centric Castleman's Disease
01/2013
1Hypergammaglobulinemia (Hyperimmunoglobulinemia)
01/2013
1Xanthomatosis (Xanthoma)
11/2007
1Atherosclerosis
11/2007
1Cardiomyopathies (Cardiomyopathy)
10/2007
1Glycogen Storage Disease (Glycogenosis)
01/2005
1Aneuploidy (Aneuploid)
07/2004
1Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
12/2002
1Autoimmune Pancreatitis
04/2002
1Nephrotic Syndrome (Syndrome, Nephrotic)
03/2002
1Lipoprotein Glomerulopathy
03/2002
1Proteinuria
03/2002
1Hyperlipoproteinemias
02/2002

Drug/Important Bio-Agent (IBA)

7Glycogen Debranching Enzyme System (Glycogen Debranching Enzyme)IBA
02/2015 - 01/2002
5ApolipoproteinsIBA
09/2014 - 02/2002
4LipidsIBA
03/2021 - 02/2012
4GlycogenIBA
02/2015 - 01/2005
3Glucose (Dextrose)FDA LinkGeneric
05/2019 - 07/2013
3Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
03/2016 - 10/2003
3AntibodiesIBA
03/2016 - 01/2013
2Apolipoprotein C-II (ApoC2)IBA
11/2017 - 01/2015
2Sitagliptin Phosphate (Januvia)FDA Link
12/2016 - 11/2013
2Insulin (Novolin)FDA Link
03/2016 - 01/2015
2Apolipoproteins E (ApoE)IBA
09/2014 - 03/2002
2Lipoproteins (Lipoprotein)IBA
12/2012 - 03/2002
2Lipase (Acid Lipase)FDA Link
12/2012 - 03/2009
2TransferasesIBA
11/2009 - 01/2009
2EnzymesIBA
11/2009 - 01/2009
2Lipoprotein(a)IBA
06/2008 - 09/2007
2Lipoprotein Lipase (Diacylglycerol Lipase)IBA
11/2007 - 11/2007
2AutoantibodiesIBA
10/2003 - 12/2002
1CanagliflozinIBA
05/2019
1Sodium-Glucose Transport ProteinsIBA
05/2019
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2019
1Islet Amyloid PolypeptideIBA
01/2019
1HLA-A*24:02 antigenIBA
03/2018
1NivolumabIBA
03/2018
1Blood Glucose (Blood Sugar)IBA
03/2018
1Hemoglobins (Hemoglobin)IBA
03/2018
1HLA Antigens (Human Leukocyte Antigens)IBA
03/2018
1SteroidsIBA
03/2018
1HLA-DRB1 Chains (HLA DRB1)IBA
03/2018
1CreatinineIBA
01/2018
1Estrogens (Estrogen)FDA Link
11/2017
1repaglinide (Prandin)FDA Link
12/2016
1AntigensIBA
03/2016
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
08/2015
1Angiotensin Receptor AntagonistsIBA
08/2015
1Protein Isoforms (Isoforms)IBA
09/2014
1SugarsIBA
07/2013
1Interleukin-6 (Interleukin 6)IBA
01/2013
1HDL CholesterolIBA
03/2010
1VLDL LipoproteinsIBA
03/2010
1GlucosidasesIBA
11/2009
1Proteins (Proteins, Gene)FDA Link
01/2009
1Nonsense Codon (Nonsense Mutation)IBA
10/2007
1Telomerase (Telomerase Reverse Transcriptase)IBA
07/2004
1EpitopesIBA
10/2003
1HLA-DQ Antigens (HLA-DQ)IBA
12/2002
1HLA-DQA1 antigen (HLA DQA1)IBA
12/2002
1Adrenal Cortex Hormones (Corticosteroids)IBA
04/2002
1Apolipoprotein E2IBA
03/2002

Therapy/Procedure

4Therapeutics
03/2018 - 11/2013
2Glycemic Control
03/2021 - 08/2015
1Liver Transplantation
09/2013